Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Comparison of azithromycin level in tears and in conjunctiva after repeated instillations of T1225 1.5 percent eye drops or after a single per Os administration of Zithromax (azithromycin 1g), in 36 healthy volunteers

Next Previous
Trial Profile

Comparison of azithromycin level in tears and in conjunctiva after repeated instillations of T1225 1.5 percent eye drops or after a single per Os administration of Zithromax (azithromycin 1g), in 36 healthy volunteers

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 14 Feb 2008

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Azithromycin (Primary)
  • Indications Bacterial infections; Ophthalmic infections
  • Focus Pharmacokinetics

Most Recent Events

  • 14 Feb 2008 The expected completion date for this trial is now 1 Mar 2003.
  • 01 Nov 2006 New trial record.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top